Astellas spending $150 million on new US headquarters
This article was originally published in Scrip
Astellas is to spend around $150 million on new headquarters facilities for its operations in the US. The two buildings in Glenview, Illinois are scheduled for completion in the spring of 2012.
You may also be interested in...
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.